Comparing Fesoterodine vs Tolterodine
| Fesoterodine | Tolterodine |
|
|---|
| Fesoterodine | Tolterodine |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Urinary Frequency, Urinary Incontinence, Overactive Bladder. Fesoterodine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Urinary Incontinence, Overactive Bladder, Urinary Frequency. Tolterodine may also be used for purposes not listed in this medication guide. |
Related suggestions Urinary Frequency
Urinary Incontinence
Overactive Bladder
|
|||||||
| More about Fesoterodine | More about Tolterodine | ||||||||
| Ratings & Reviews | |||||||||
|
Fesoterodine has an average rating of 5.3 out of 10 from a total of 77 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 36% reported a negative effect. |
Tolterodine has an average rating of 6.3 out of 10 from a total of 77 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 25% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Fesoterodine side effects |
View all Tolterodine side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
Lower cost generic |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Tolterodine prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Toviaz | Detrol, Detrol LA | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
7 hours |
3.7 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 321 drugs are known to interact with Fesoterodine:
|
A total of 636 drugs are known to interact with Tolterodine:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
October 31, 2008 |
March 25, 1998 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Myrbetriq
Myrbetriq (mirabegron) is used to treat overactive bladder with symptoms of frequent or urgent ...
Detrol
Detrol is used to treat overactive bladder symptoms of urinary frequency, urgency, and ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
VESIcare
Vesicare is used to treat symptoms of overactive bladder such as incontinence and frequent ...
Ditropan
Ditropan XL (oxybutynin extended release) is used to treat the symptoms of overactive bladder ...
Toviaz
Toviaz (fesoterodine) is used to treat overactive bladder with symptoms of urinary frequency ...
Trospium
Trospium is used for interstitial cystitis, overactive bladder, urinary frequency, urinary incontinence
Tolterodine
Tolterodine is used for overactive bladder, urinary frequency, urinary incontinence
Mirabegron
Mirabegron is used for neurogenic detrusor overactivity, overactive bladder, urinary frequency ...
Solifenacin
Solifenacin (Vesicare) is used to treat overactive bladder symptoms such as frequent or urgent ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.